Non-statin LDL-lowering therapy and cardiovascular risk reduction: beyond plasmatic LDL-cholesterol regulation
Dimitris Tousoulis, Athens, GR
Charalambos Antoniades, Oxford, UK
PCSK9 functions beyond plasmatic LDL-cholesterol regulation
Lina Badimon, Barcelona, Spain
Questions and Answers
During the Q&A, participants will have the opportunity to interact with the chairs and speaker by asking their questions verbally using the “Raise hand” feature or in written form using the "Q&A" module. Chairs and speaker can answer directly in the module (publicly or privately) or discuss live during the Q&A.
Registration for this event is now closed.
The event recording will be accessible on demand two weeks after the live event.